Education Forum IX: TILs, TCRs, CAR T-Cells and Immune Checkpoint Inhibitors in Gynecologic Cancer Care, An Update

Education Forum

Oliver Dorigo, MD, Stanford Hospital and Clinics, Stanford, CA
Kathleen Moore, MD, University of Oklahoma Medical Center, Oklahoma City, OK

Description: This session will focus on immunotherapies beyond immune checkpoint inhibition, including CAR T cells, TIL and vaccine therapies.

Location: Kalakaua A